Coronavirus vaccine update: Serum vs volunteer fight, PM calls meet, & more


 

A trial participant claims to have suffered a neurological illness (acute encephalopathy) and was hospitalised 10 days after he received the first jab of the vaccine in the Covishield trial. He sent a legal notice to the Serum Institute of India (SII), the sponsor of the trial, seeking Rs 5 crore in damages.

Serum Institute has in response stated that the allegations made in the legal notice are ‘malicious and misconceived’, and that it will seek damages in excess of Rs 100 crore. Read More

Comments

Popular posts from this blog

Invest in smallcase with sebi registered professionals

Teji Mandi Your Ultimate Share Market App for Informed Investing

Unleashing the Potential of Stocks: Crafting a Successful Stock Portfolio